Pacira BioSciences, Inc. — Director's Dealing 2021

Mar 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-03-15

Reporting Person: Riker Lauren Bullaro (Vice President, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	M	1520	$10.81	Acquired	14701	Direct
2021-03-15	Common Stock	S	1520	$73.28	Disposed	13181	Direct
2021-03-17	Common Stock	M	2000	$10.81	Acquired	15181	Direct
2021-03-17	Common Stock	S	2000	$70.01	Disposed	13181	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$10.81	M	1520	Disposed	2022-06-05	Common Stock (1520)	Direct
2021-03-17	Stock Option (Right to Buy)	$10.81	M	2000	Disposed	2022-06-05	Common Stock (2000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.03 to $73.50, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.04, inclusive.

F3: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months.